TCL Archive In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director March 17, 1995
TCL Archive FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention” November 6, 1998
TCL Archive NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial. April 20, 2007
TCL Archive NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands October 15, 1999
